Aratana Therapeutics, Inc.(NASDAQ : PETX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Generic
|TEVA||Teva Pharmaceutical Industries Ltd.||-1.65%||8.03||2.0%||$79.79m|
|RDY||Dr. Reddy's Laboratories Ltd.||-2.76%||60.68||2.0%||$7.46m|
|JAGX||Jaguar Health, Inc.||-7.09%||1.18||2.6%||$1.71m|
|TARO||Taro Pharmaceutical Industries Ltd.||-1.81%||51.00||6.6%||$0.74m|
|COCP||Cocrystal Pharma, Inc.||-7.60%||0.71||0.0%||$0.62m|
|ABEO||Abeona Therapeutics, Inc.||-4.31%||0.58||3.7%||$0.55m|
|CPHI||China Pharma Holdings, Inc.||-5.10%||0.50||0.1%||$0.22m|
Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.